Electrotherapy Devices (TENS, EMS) in Texas

AccuMed Biotech is a US-based medical device and safety product supplier headquartered in Houston, Texas. The company manufactures and distributes a range of consumer health monitoring devices and personal protective equipment. Primary product lines include N95 and KN95 respirator masks, infrared thermometers, pulse oximeters, pregnancy and fertility rapid tests, and electrotherapy/TENS (transcutaneous electrical nerve stimulation) units for muscle stimulation and massage. AccuMed also offers MERV 13 AC air filters for residential and commercial HVAC applications. The company emphasizes domestic manufacturing, with products marketed as "Made in USA." Product catalog includes both medical-grade and consumer-grade devices suitable for home use, clinical settings, and workplace safety. AccuMed operates a B2C e-commerce platform with account management, order tracking, and customer support functionality. The product portfolio reflects focus on accessible, affordable personal health monitoring and occupational safety equipment without advanced imaging or diagnostic capabilities. All products align with standard consumer health and safety applications.

ManaMed is a recovery and rehabilitation equipment manufacturer specializing in wearable therapeutic devices for post-injury and post-surgical recovery. The company produces a comprehensive product portfolio focused on neuromuscular electrical stimulation (NMES), transcutaneous electrical nerve stimulation (TENS), therapeutic ultrasound, compression therapy, cold therapy, and orthopedic supports. Key product lines include the ManaFlexx 2 (wireless NMES/TENS device), ManaSport+ (at-home therapeutic ultrasound), ManaCold Platinum 2.0 (water-circulating cold therapy system), ManaFlow 51 (cordless compression device for lymphedema management), ManaGo 71 (ankle brace), gOAt (knee brace), Kahuna (shoulder brace), ManoFX (hand/fracture brace), Tailback2 50 (spine orthosis), and MAC Walker Boot Air (foot/ankle support). ManaMed serves athletes, clinical rehabilitation settings, and consumers managing recovery from musculoskeletal injuries and surgical procedures. The company markets heavily toward sports medicine and athletic training, with documented partnerships in professional sports (UFC). Products are designed for at-home and clinical use, emphasizing cordless, portable, and user-friendly therapeutic delivery. The company maintains an active product catalog and operates a direct-to-consumer sales channel alongside professional healthcare distribution.

Ampcare manufactures and distributes the Effective Swallowing Protocol (ESP), a neuromuscular electrical stimulation (NMES) system combined with resistive exercise and restorative posture devices for dysphagia (swallowing disorder) treatment. The ESP protocol targets swallow anatomy, provides airway resistance, and uses perturbation science to accelerate airway closure time, reducing aspiration risk. The system features patented electrode design with larger contact surfaces to minimize patient discomfort ("hot spots") compared to competing NMES devices. Ampcare positions cost-effectiveness as a competitive advantage, citing $1.63 per-treatment electrode cost. The company offers comprehensive speech-language pathology (SLP) training through ASHA CE-accredited certification workshops available in live classroom (4–8 hours in-person), on-demand, and hybrid formats. Training covers anatomy, physiology, muscle fiber recruitment, electrotherapy principles, and evidence supporting the ESP protocol. Ampcare targets speech-language pathologists and swallow therapy clinicians in rehabilitation and outpatient settings. The product is supported by published research demonstrating functional improvements in swallow safety and patient outcomes.

Flowpresso USA manufactures and distributes Flowpresso®, a prescription-only Class II medical device combining cyclic pneumatic compression therapy with thermotherapy (heat) and deep pressure therapy for lymphatic care and autonomic nervous system regulation. The system features four independently adjustable compression chambers (feet, legs, trunk, arms) with customizable heat settings and a touchscreen interface. Standard treatment sessions run 40 minutes. Target markets include chiropractors, physical therapists, naturopathic doctors, surgeons, physicians, and biological dentists. The device is designed to enhance lymphatic drainage, reduce pain and inflammation, support post-surgical and post-trauma recovery, improve circulation, reduce stress, and promote parasympathetic activation. Materials include PVC tested for safety. The company provides practitioner onboarding, training, and customer support. No specific FDA 510(k) clearance or ISO certification details are stated on the site, though the device is described as regulated and evidence-backed.

Medico Electrodes International Limited is one of the world's leading manufacturers of disposable ECG electrodes for cardiac monitoring and diagnostic procedures. Founded in 2002 and operating from a state-of-the-art manufacturing facility in Noida SEZ since 2006, the company is the third largest global manufacturer of disposable snap electrodes and the largest outside the USA. The product portfolio includes high-quality ECG electrodes, TENS/EMS electrodes for therapeutic applications, ESU pads for electrosurgery, and conductive hydrogels. Manufacturing adheres to stringent global standards with rigorous electrical and mechanical testing to ensure reliable conductivity, signal quality, adhesion strength, and durability. The company holds ISO 13485 certification, CE Mark compliance (2017/745/EU MDR), and MDSAP guideline adherence, reflecting commitment to regulatory standards and quality assurance. Products are designed for precision, patient comfort, and optimal conductivity across cardiac monitoring, diagnostic, and therapeutic applications. The company serves healthcare facilities and diagnostic centers globally, with 20+ years of experience in medical electrode development and manufacturing.

ThermoTek is a leading manufacturer of innovative thermoelectric medical and aesthetic solutions, founded in 1993 with over 30 years of experience. The company specializes in thermal management devices for post-surgical pain management, edema reduction, and deep vein thrombosis (DVT) prevention. Core product lines include the VascuTherm 5 (thermal, compression, and DVT therapy system), ARTEK Pro (thermoelectric device integrating cold, heat, and compression for post-surgical recovery), ARTEK Sport (portable ice therapy system), and Aesthetic Therapy (contact cooling for cosmetic procedures). ThermoTek also partners with Dignitana to offer DigniCap Delta, a thermoelectric scalp-cooling system for chemotherapy patients. The company operates across three sectors: medical (orthopedic surgery recovery, post-operative pain management), aesthetic (patient comfort during cosmetic procedures), and scientific/custom applications (thermal management for laser, semiconductor, and military industries). Products feature ice-less cooling technology with automatic on/off cycles. ThermoTek maintains ISO-certified quality standards and holds multiple active patents. The company distributes through an authorized dealer network across the United States and serves veterans through partnership with Veterans Affairs. Products are designed to comply with regulatory standards and improve patient outcomes while reducing dependence on pain medications.

NeuFit (operating as Neurological Fitness Equipment and Education LLC) manufactures and distributes the Neubie, an FDA-cleared direct current (DC) electrical stimulation device designed for tissue healing, neuromuscular re-education, and neurological rehabilitation. The Neubie is used across orthopedic recovery, neurological conditions (stroke, spinal cord injury, traumatic brain injury), athletic performance enhancement, and pain management. The company provides a comprehensive methodology called the NeuFit Method, which combines device stimulation with targeted movements and manual techniques to identify neurological limitations, reset dysfunctional patterns through neuroplasticity, and facilitate functional breakthroughs. The platform serves physical therapists, occupational therapists, chiropractors, physicians, athletic trainers, and sports teams. NeuFit reports 400+ clinics, 4,000+ certified practitioners, 75+ professional sports teams, and 15+ universities using the Neubie. Clinical outcomes reported include 90% of users experiencing tangible improvements in the first session, with reductions in pain, increased mobility, improved range of motion, and accelerated recovery timelines. The device is FDA-cleared (510(k)) and subject to US regulatory requirements limiting commercial use to licensed practitioners or under licensed practitioner supervision. The company emphasizes education through practitioner certification programs and provides business support materials for clinical practices incorporating the technology.

InterX Technologies manufactures FDA-cleared, non-invasive neuromodulation devices for the treatment of acute, post-surgical, and chronic neuropathic pain. The company's primary product line includes the InterX® 5002 (professional) and InterX® 1000 (personal) devices, which deliver interactive neurostimulation directly to the skin without conductive gel. Both devices employ patented flex array impedance-seeking electrode pads and are compatible with multiple electrode accessories, including the newly launched XPad®—a flexible, adhesive, cut-to-fit conductive pad for dynamic muscle groups and high-movement zones. InterX devices are used across clinical, sports medicine, military, and home-care settings. The company serves physical therapists, chiropractors, athletic trainers, healthcare professionals, and individual patients. Markets include professional sports (NFL, NBA, MLB, NHL), U.S. military and Veterans Affairs, academic medical centers (Duke Health, Texas Health), and specialized therapy clinics. All devices and accessories are backed by broad patents and clinical evidence. InterX operates training centers and licensing programs for healthcare professionals. The company ships within the United States only.

Xstim, Inc. manufactures the Xstim Spine Fusion Stimulator, a Class III FDA-approved electrical stimulation device designed to promote bone healing and fusion success following lumbar spinal fusion surgery. The device uses capacitive coupling technology to deliver low-level electrical impulses to the fusion site through hydrogel electrodes placed 4–6 inches apart adjacent to the surgical site. Clinical evidence demonstrates upregulation of bone morphogenetic proteins (BMPs) and multiple growth factors, with reported fusion success rates up to 85% in one- or two-level lumbar fusions. The technology is based on peer-reviewed research showing that specific electrical stimulation signals enhance bone healing phases within 30 minutes of exposure, with optimal effects at 24 hours. The Xstim device is compact, lightweight, and portable, designed for discreet, patient-driven treatment during the post-operative recovery and rehabilitation period. The company targets orthopedic surgeons, spine surgery centers, and patients recovering from lumbar fusion procedures. Regulatory approval includes FDA PMA (Premarket Approval) P230025. The product represents a non-invasive adjunct therapy aimed at improving clinical outcomes and reducing fusion failure rates in spine surgery patients.

Avazzia, Inc. manufactures prescription-level and over-the-counter microcurrent devices for acute and chronic pain management. The company's proprietary Reaction Technology platform delivers symptomatic relief and pain management lasting up to 24 hours. Avazzia's product portfolio includes the Med-Sport device (over-the-counter for muscle soreness), the BEST-RSI device (prescription-required for acute and chronic pain), and the PRO-SPORT III device with LED display (prescription-required). All devices are FDA-cleared for symptomatic relief and management of chronic, intractable pain, and as adjunctive treatment in post-surgical and post-traumatic pain management. The company maintains a strong commitment to evidence-based clinical research and supports the Paralyzed Veterans Association, with devices available through VA healthcare facilities. Accessories including Y-electrode bundles enable targeted treatment delivery. Founded over two decades ago, Avazzia operates with clinical research support and maintains active engagement with healthcare providers and patient populations seeking non-pharmacological pain relief alternatives.

Electromedical Products International (EPII) manufactures Alpha-Stim®, a family of FDA-cleared cranial electrotherapy stimulation (CES) devices for treatment of anxiety, insomnia, depression, and acute/chronic pain without medication. The company offers two primary product lines: Alpha-Stim M (a wearable electrotherapy device approved for anxiety, insomnia, depression, and pain management) and Alpha-Stim AID (designed for anxiety, insomnia, and depression). Alpha-Stim devices deliver low-level electrical microcurrent to the brain via ear clip electrodes, providing drug-free symptom relief suitable for both clinical and home settings. Products are prescribed by healthcare professionals globally and marketed directly to patients through their online store and telehealth consultation platform. The company supports clinical adoption with patient education resources, provider demos, and customer support services including product registration, warranty, and returns. EPII operates a customer service center accessible by phone (1-800-367-7246 / +940-328-0788) and email. The device platform targets anxiety disorders, sleep disturbances, depression (outside US), and pain management across diverse patient populations including active-duty military, first responders, and general wellness consumers. Manufacturing and regulatory credentials include FDA 510(k) clearance for marketed indications.

Mind Media Group manufactures and supplies EEG-based neurotechnology platforms for clinical, research, and educational applications. The company's core product line is the NeXus system—a multimodal biosensor platform available in wireless configurations (NeXus 10 MK3, NeXus Q24, NeXus Q32)—designed for nervous system sensing and real-time biofeedback/neurofeedback training. NeXus integrates EEG acquisition with sensors for physiological measurement (heart rate variability, skin conductance, respiration) and connects to Biotrace+, proprietary software for quantitative EEG (qEEG), biofeedback protocols, and neurofeedback applications. The platform serves three primary markets: clinical practice (mind-body assessments, therapeutic training for PTSD, ADHD, anxiety, depression), research (3000+ peer-reviewed publications), and education (certification and practitioner development). Complementary offerings include EEG caps, sensors, and cables. The company is widely adopted by major medical centers (Mayo Clinic, Cleveland Clinic, Kaiser Permanente), military and VA health systems (Walter Reed, multiple VA facilities, Department of Defense), academic institutions (MIT, Harvard, Max Planck Institute), and specialized centers (Rady Children's Hospital, Schön Klinik). Mind Media provides comprehensive training and education through its Path to Mastery Academy, offering courses from biofeedback basics through certified practitioner certification. The platform supports clinical assessment, performance optimization, and neuroscience research. Regulatory status, ISO certifications, and FDA classification status are not explicitly stated in available content.

ERGO-FLEX Technologies is a Texas-based manufacturer of hands-free, automated therapy systems designed for chiropractic, physical therapy, and integrative health clinics. Since 2011, the company has developed non-surgical, drug-free pain relief and rehabilitation technologies. Core products include Back On Trac (FDA-cleared spinal decompression system with axial distraction and lateral flexion), Cervi-Trac (automated cervical traction), Knee On Trac (standalone knee traction device), Mito2 (3-in-1 responsive oxygen therapy system combining IHHT, EWOT, and recovery modes), and SomaCharge (clinical-grade PEMF therapy system). All equipment is manufactured and assembled in Conroe, Texas, featuring compact footprints, fully automated protocols, and minimal staff requirements. These solutions target chronic pain management, joint decompression, cellular energy optimization, and performance recovery across diverse wellness settings including med spas, gyms, and day spas.

Wegamed GmbH is a holistic medical technology company with 20+ years of experience in developing and distributing diagnostic and therapeutic wellness devices. The company specializes in non-invasive, drugless alternatives for health assessment and treatment, serving wellness professionals, clinics, and healthcare practitioners. Wegamed's product portfolio includes diagnostic devices (such as Prefit Bodyscan systems for comprehensive health analysis), therapeutic devices (Med Select for activating the body's self-healing mechanisms, and Med Matrix for whole-body detoxification), and wellness devices designed to support holistic health practices. All products are CE-certified medical devices and backed by clinical research. The company operates a comprehensive academy offering beginner and professional seminars for practitioners, and provides turnkey wellness hub solutions through Wegamed Wellness Center and Wellbeing Point offerings. Wegamed emphasizes identifying and treating underlying causes rather than symptom management, positioning its technology as a complement to conventional medical practice. The company serves international markets and works through partnerships with wellness professionals, clinics, and channel partners. Manufacturing and quality standards include TÜV certification and adherence to medical device regulations.

Nexalin Technology manufactures a non-invasive, drug-free medical device for transcranial electrical stimulation (TES) targeting anxiety, depression, and insomnia. The device delivers a patented waveform that stimulates deep midbrain structures to normalize neurochemical imbalances, particularly increasing beta-endorphins and modulating serotonin and dopamine levels. FDA-classified as a non-significant risk device, it delivers 40-minute home-based treatments with no reported side effects. Clinical data indicates 60–80% symptom reduction rates. The company markets to both healthcare providers seeking to establish virtual treatment clinics and direct-to-consumer patients. The technology addresses the growing mental health epidemic in the United States through an evidence-based, medication-free alternative.

Medi-Dyne Healthcare Products is a manufacturer and distributor of over-the-counter pain relief, injury prevention, and mobility support products. The company markets four proprietary brands: ProStretch® (calf stretchers, shoulder stretching devices, nightsocks, and core strengthening tools), Tuli's® (heel cups, arch supports, plantar fasciitis insoles, ankle/foot braces, and toe straighteners), Cho-Pat® (knee straps, bicep/tricep supports, and achilles tendon straps), and 2Toms® (anti-chafing, blister prevention, and odor control products for athletes and active users). Products are designed for runners, athletes, and individuals managing common musculoskeletal conditions including plantar fasciitis, heel pain, knee pain, calf tightness, rotator cuff issues, and sports-related injuries. The company offers comprehensive educational resources including a Pain Solution Center with injury prevention guides, exercise instructions, and product use videos. Medi-Dyne maintains a B2B wholesale division with reseller support and distribution programs. Products are marketed as HSA/FSA eligible. Distribution occurs through direct-to-consumer e-commerce, wholesale/reseller channels, and retail partnerships.